MITAZALIMAB
UNII Q9J81E7VFM

Substance Identification & Data

This profile provides standardized clinical and technical data for Mitazalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q9J81E7VFM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2055640-86-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q9J81E7VFM

CAS Registry Number

2055640-86-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MITAZALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C121538

National Cancer Institute reference terminology for clinical and research data.

INN ID

10764

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mitazalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MITAZALIMAB

Common Names & Synonyms

AGONISTIC ANTI-CD40 MONOCLONAL ANTIBODY ADC-1013

IMMUNOGLOBULIN G1, ANTI-(CD40 ANTIGEN) (HUMAN MONOCLONAL JNJ-64457107 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-64457107 .LAMBDA.-CHAIN, DIMER

MITAZALIMAB [INN]

MITAZALIMAB [WHO-DD]

VANALIMAB